$100.58 -0.50 (%) Johnson & Johnson - NYSE

Apr. 27, 2015 | 04:00 PM

Partner Headlines

  1. DepoMed Set To Grow On 'Transformative' Nucynta Deal

    IBD | Apr. 23, 2015 | 16:16PM EST
  2. IBM Earnings Continue To Reflect Transition Challenge

    IBD | Apr. 20, 2015 | 18:36PM EST
  3. IBM Transition In Focus With Q1 Earnings

    IBD | Apr. 18, 2015 | 08:02AM EST
  4. Hottest ETF Strategy: Factor Investing In Stocks

    IBD | Apr. 17, 2015 | 20:04PM EST
  5. What Were The Major Takeaways From Johnson & Johnson's First Quarter Earnings?

    GuruFocus | Apr. 16, 2015 | 17:53PM EST
  6. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  7. 5 Best U.S. Dividend Growth Stocks

    GuruFocus | Apr. 15, 2015 | 21:17PM EST
  8. Johnson & Johnson Beats Market Expectations

    GuruFocus | Apr. 15, 2015 | 18:22PM EST
  9. Biotech IPOs Ignite As Aduro Doubles On First Day

    IBD | Apr. 15, 2015 | 13:57PM EST
  10. Will Health Tech Really Make Us Healthier?

    FoxBusiness | Apr. 15, 2015 | 12:15PM EST
  11. What Specific Role Will Apple Play In IBM's Watson Health Cloud Alliance?

    Benzinga | Apr. 15, 2015 | 08:51AM EST
  12. Johnson & Johnson: Currency Headwinds Impacts Q1 Results

    GuruFocus | Apr. 14, 2015 | 22:58PM EST
  13. An Apple Watch A Day And IBM To Keep Doctor Away?

    IBD | Apr. 14, 2015 | 19:16PM EST
  14. J&J profit beats, cuts guidance

    IBD | Apr. 14, 2015 | 19:03PM EST
  15. Making Money With Charles Payne: 04/14/15

    FoxBusiness | Apr. 14, 2015 | 18:00PM EST
  16. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  17. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  18. Stocks Set For Soft Start; JPMorgan, Wells Fargo Top Views

    IBD | Apr. 14, 2015 | 08:55AM EST
  19. Johnson & Johnson Posts Upbeat Q1 Earnings, But Lowers FY15 Forecast

    Benzinga | Apr. 14, 2015 | 08:10AM EST
  20. 7 Stocks You Should Be Watching Today

    Benzinga | Apr. 14, 2015 | 04:01AM EST
  21. IBM

    IBD | Apr. 13, 2015 | 18:53PM EST
  22. IBM Pulls Apple, J&J Into Watson Health Data Alliance

    IBD | Apr. 13, 2015 | 18:49PM EST
  23. Stocks Give Up Early Gains, Apple Also Reverses Lower

    IBD | Apr. 13, 2015 | 16:36PM EST
  24. Stock Investors Dig In For Bank Earnings, Ready For Next SPX Test

    Benzinga | Apr. 13, 2015 | 13:59PM EST
  25. Stocks Poised For Soft Start; Qualcomm Up Big Premarket

    IBD | Apr. 13, 2015 | 08:59AM EST
  26. Benzinga's M&A Chatter for Monday March 2, 2015

    Benzinga | Mar. 2, 2015 | 19:29PM EST
  27. 'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals

    Benzinga | Mar. 2, 2015 | 13:19PM EST
  28. Cardinal Health To Buy J&J Cardiology Device Unit

    IBD | Mar. 2, 2015 | 08:36AM EST
  29. UPDATE: Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis

    Benzinga | Mar. 2, 2015 | 07:31AM EST
  30. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD | Feb. 26, 2015 | 09:56AM EST
  31. Benzinga's M&A Chatter for Wednesday February 25, 2015

    Benzinga | Feb. 25, 2015 | 21:26PM EST
  32. Pharmacyclics hits new high

    IBD | Feb. 25, 2015 | 18:51PM EST
  33. Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'

    Benzinga | Feb. 25, 2015 | 17:05PM EST
  34. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  35. Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit

    GuruFocus | Feb. 24, 2015 | 10:42AM EST
  36. 3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis

    Benzinga | Feb. 23, 2015 | 13:57PM EST
  37. Morgan Stanley Analyst Sees Higher Net For Cardinal Health In Johnson & Johnson Deal

    Benzinga | Feb. 23, 2015 | 11:45AM EST
  38. Johnson & Johnson: Why Investors Should Consider This Stock for Long-Term Gains

    GuruFocus | Feb. 22, 2015 | 19:00PM EST
  39. Can These Three BioTech Companies Make It Big?

    GuruFocus | Feb. 20, 2015 | 15:22PM EST
  40. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  41. Paul Tudor Jones Is Betting on the SPY, Should You?

    GuruFocus | Feb. 20, 2015 | 13:05PM EST
  42. 10 Stocks Institutional Investors Loved Last Quarter

    Benzinga | Feb. 20, 2015 | 11:38AM EST
  43. Sterne Agee To Investors: Caution! Boston Scientific Priced To Perfection

    Benzinga | Feb. 20, 2015 | 09:08AM EST
  44. Medtronic Q3 Earnings 2015 Exceeds Market Expectations

    GuruFocus | Feb. 19, 2015 | 17:23PM EST
  45. Retirement ETFs To Look For

    GuruFocus | Feb. 19, 2015 | 12:58PM EST
  46. Boston Scientific Closes Up 12%

    Benzinga | Feb. 18, 2015 | 16:44PM EST
  47. Boston Scientific Soars 11% After Settling Dispute With Johnson & Johnson

    Benzinga | Feb. 18, 2015 | 14:42PM EST
  48. Mid-Day Market Update: Angie's List Jumps On Upbeat Earnings; MedAssets Shares Tumble

    Benzinga | Feb. 18, 2015 | 12:51PM EST
  49. Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson ...

    GuruFocus | Feb. 18, 2015 | 11:36AM EST
  50. Sterne Agree Weighs In On Boston Scientific-Johnson & Johnson Litigation Settlement

    Benzinga | Feb. 18, 2015 | 10:24AM EST
Trading Center